Related references
Note: Only part of the references are listed.NOVEL MOLECULAR TARGETS OF THE NEUROPROTECTIVE/NEURORESCUE MULTIMODAL IRON CHELATING DRUG M30 IN THE MOUSE BRAIN
L. Kupershmidt et al.
NEUROSCIENCE (2011)
Neuroprotective Multifunctional Iron Chelators: From Redox-Sensitive Process to Novel Therapeutic Opportunities
Orly Weinreb et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Up-Regulation of Hypoxia-Inducible Factor (HIF)-1α and HIF-Target Genes in Cortical Neurons by the Novel Multifunctional Iron Chelator Anti-Alzheimer Drug, M30
Y. Avramovich-Tirosh et al.
CURRENT ALZHEIMER RESEARCH (2010)
Prodeath or prosurvival: Two facets of hypoxia inducible factor-1 in perinatal brain injury
Wanqiu Chen et al.
EXPERIMENTAL NEUROLOGY (2009)
Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis
Lana Kupershmidt et al.
FASEB JOURNAL (2009)
Inhibition of Prolyl Hydroxylase Protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Neurotoxicity MODEL FOR THE POTENTIAL INVOLVEMENT OF THE HYPOXIA-INDUCIBLE FACTOR PATHWAY IN PARKINSON DISEASE
Donna W. Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Prolyl 4-hydroxylase activity-responsive transcription factors: From hydroxylation to gene expression and neuroprotection
Ambreena Siddiq et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease
Yael Avramovich-Tirosh et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators
Wen Zhu et al.
FASEB JOURNAL (2007)
Role of HIF-1 in iron regulation: Potential therapeutic strategy for neurodegenerative disorders
Donna W. Lee et al.
CURRENT MOLECULAR MEDICINE (2006)
Hypoxia-inducible factor prolyl 4-hydroxylase inhibition - A target for neuroprotection in the central nervous system
A Siddiq et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases:: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition
H Zheng et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Synthesis and evaluation of peptidic metal chelators for neuroprotection in neurodegenerative diseases
H Zheng et al.
JOURNAL OF PEPTIDE RESEARCH (2005)
Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion
S Gal et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders
MBH Youdim et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats
D Ben Shachar et al.
NEUROPHARMACOLOGY (2004)
Iron, brain ageing and neurodegenerative disorders
L Zecca et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Oxygen sensing by HIF hydroxylases
CJ Schofield et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript
JT Rogers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology
GL Semenza
TRENDS IN MOLECULAR MEDICINE (2001)
Share Paper
